Who are Diana Health's decision-makers?
Diana Health's public leadership centers on Kate Condliffe, Jim Corum, Da Chang, Christopher Sizemore, DO. Buying decisions vary by category but generally include executive, clinical, operations, product, compliance, security, and finance stakeholders.
- CEO
- Kate Condliffe
- CTO/key exec
- Jim Corum
- Founded
- 2019
- Employees
- 201-500 reported range
- HQ
- New York, NY
- Notable
- Private; Series C
- Kate CondliffeCEO & Co-founderFounderLeads Diana's hospital-partnered women's health model.
- Jim CorumChief Growth Officer & Co-founderFounderLeads growth and market partnerships.
- Da ChangPresident & COOCurrent executiveLeads operations and scale.
- Christopher Sizemore, DOChief Medical OfficerCurrent executiveClinical leader for women's health services.
Who leads Diana Health?
Kate Condliffe, Jim Corum, Da Chang, Christopher Sizemore, DO are the key public leaders in this profile. Their backgrounds indicate where strategy, clinical credibility, operations, product, and commercialization decisions are likely anchored.
Who actually makes buying decisions at Diana Health?
For clinical, patient, or payer-facing software, buying decisions usually require executive sponsorship plus clinical, compliance, legal, security, finance, and product review. For GTM, workforce, or back-office tools, operations and finance may lead but compliance and security still gate deployment.
How is Diana Health organized as it scales?
Diana Health appears organized around product, clinical or healthcare operations, customer growth, compliance, data, and partnerships. Sellers should align outreach to the operational problem they solve instead of starting with only the CEO.
As of June 2026.Sources:Diana homepageDiana leadershipDiana Series C
Diana Health — frequently asked questions
